Tuberculosis in Juvenile Idiopathic arthritis under Anti-TNF therapy by Cerqueiro C, Giupponi J, Espada G

Connect to this object online.

Safety of anti-TNF therapy: 10 year experience in pediatric patients from a single tertiary center by Giupponi, Alvarez M, Guerini L, Meiorin SM, Espada G

Connect to this object online.

13.4 High frequency of CNS involvement in linear scleroderma of the face by Parolin M, Russo R, Corona F, de Oliveira SKF, Nowakowska EM, Sztajnbok F, Chaitow J, Espada G, Desjonqueres M, Ullman S, Zulian F

Connect to this object online.

Therapeutic approaches for the treatment of new onset and flared juvenile systemic lupus erythematosus with active renal disease: an international multicenter PRINTO study by Palmisani E, Sztajnbok F, Porras O, Ozen S, Cortis E, Pasic S, Espada G, Mihaylova D, Cuttica R, Alessio M, Oliveira S, Ravelli A, Pistorio A, Miettunen P, Martini A, Ruperto N

Connect to this object online.

2.3 Long-term efficacy and safety of infliximab plus methotrexate for the treatment of polyarticular course juvenile rheumatoid arthritis (JRA): Findings from an open-label treatme... by Ruperto N, Lovell DJ, Cuttica R, Woo P, Espada G, Wouters C, Silverman ED, Balogh Z, Henrickson M, Davidson J, Foeldvari I, Imundo L, Simonini G, Oppermann J, Shen YK, Visvanathan S, Fasanmade A, Mendelsohn A, Martini A, Giannini EH

Connect to this object online.

Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): tender 52-week data by Espada G, Pardeo M, Chaitow J, Brown D, Allen R, Zulian F, Zuber Z, Wulffraat N, Joos R, Dolezalova P, Burgos-Vargas R, Woo P, Schneider R, Ruperto N, Brunner H, De Benedetti F, Flato B, Gerloni V, Horneff G, Wright S, Kenwright A, Lovell D, Martini A

Connect to this object online.